O20: Improved clinical management following diagnosis with familial hypercholesterolemia in the Helix Research Network Population Genomics Screening Program

Documenti analoghi

• P101: Very low penetrance of loss-of-function variants in PMS2 for all Lynch syndrome relevant cancers in large US biobanks*
  di: Alexandre Bolze, et al.
  Pubblicazione: (2025-01-01)
• O20: Improved clinical management following diagnosis with familial hypercholesterolemia in the Helix Research Network Population Genomics Screening Program
  di: Matthew Levy, et al.
  Pubblicazione: (2025-01-01)
• P580: Comparing automated vs ACMG/AMP-based variant interpretation for the CDC Tier 1 conditions in a clinicogenomic cohort from US-based health systems
  di: Kelly Schiabor Barrett, et al.
  Pubblicazione: (2025-01-01)
• P172: A framework to identify individuals at low risk of disease in the population*
  di: Alexandre Bolze, et al.
  Pubblicazione: (2025-01-01)
• P190: Scalable system-wide CYP2C19 pharmacogenomic testing reveals excess incidence of adverse events in metabolizers receiving inappropriate prescriptions
  di: Natalie Telis, et al.
  Pubblicazione: (2025-01-01)